Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 205-216 of 800 results.
"The system identifies the IV container (vessel) and its fluid content (liquid) using pixel-level segmentation and estimates the remaining fluid volume without requiring physical sensors" Sunwoo et al (2025).
"PIVC insertion is painful for patients, takes clinicians' attention away from other care, has adverse outcomes and causes major economic and environmental burden. Our aim is to codesign an implementation toolkit to reduce unnecessary PIVC insertions and improve other national quality indicators using an implementation science framework” Egerton-Warburton et al (2025).
"We present a case of a triple lumen catheter which was misplaced in a small lumbar vein side-branch while attempting a left groin approach. This finding was discovered on CT scan of the abdomen and pelvis, after which the catheter was repositioned with proper placement” Horani et al (2025).
"This meta-analysis identifies blood transfusions, congenital/CNS comorbidities, parenteral nutrition, and catheter-related practices as critical modifiable risk factors for pediatric CLABSI” Li et al (2025).
"We present the case of a 71-year-old woman with multiple comorbidities who developed a right subpectoral hematoma with active arterial bleeding following PICC line insertion” Zoghoul et al (2025).
"Almost 1 in 3 patients leaving on OPAT experienced an adverse event. A 6 Sigma analysis identified heterogeneity in our process and incorrect assumptions among stakeholders. Next steps should focus on improving ID documentation and ensuring all patients leaving on OPAT have an ID clinic visit scheduled within 14 days after discharge” Keri et al (2025).
"A prioritization study with infection preventionists using the SHEA CLABSI prevention framework identified priorities for IVCare intervention testing as: vascular access teams, education/competency for CVAD insertion/post-insertion care, sutureless securement, connector type and decontamination method” Rickard et al (2025).
"This editorial examines the current landscape of PICC utilization in cancer care, highlighting the critical intersection between evidence-based practice and patient-centered outcomes” Mussa and Defrancisco (2025).
"Contrast-enhanced computed tomography demonstrated the absence of the left brachiocephalic vein, with the left internal jugular vein joining the left subclavian vein and descending directly to the heart, confirming persistent left superior vena cava (PLSVC)”
"In conclusion, our results support flush and discard ahead of haemostatic assay blood sampling in newly inserted catheters. Furthermore, the results enhance the understanding of central venous catheter-related thrombosis formation” Naddi et al (2025).
"Hurricane Helene's disruption of Baxter's North Carolina manufacturing facility in September 2024 created significant supply disruptions and an urgent need to reduce intravenous fluid (IVF) usage across our 12 acute care hospital health system” Nahass et al (2025).
"Two months of rivaroxaban prophylaxis effectively and safely reduce CRT incidence in breast cancer patients with PICC” Sang et al (2025).
